A case-control study of cytochrome P450 1A1, glutathione S-transferase M1, cigarette smoking and lung cancer susceptibility (Massachusetts, United States)

Cancer Causes and Control

Volumn 8, Issue 4, 1997, Pages 544-553

  García Closas, Montserrat ^a   Kelsey, Karl T ^b   Wiencke, John K ^c   Xu, Xiping ^b   Wain, John C ^d   Christiani, David C ^b,d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cytochrome P450; Genotype; Glutathione transferases; Lung neoplasm; Smoking; United States

Indexed keywords

CYTOCHROME P450; GLUTATHIONE TRANSFERASE;

ADULT; AGED; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHEMICAL MODIFICATION; CIGARETTE SMOKING; DETOXIFICATION; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; GENETIC HETEROGENEITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METABOLIC ACTIVATION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HETEROZYGOTE DETECTION; HOMOZYGOTE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING;

EID: 0030764507     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018481910663     Document Type: Review

References (41)

1. Amdur MO, Doull J, Klaassen CD. Toxicology. New York, NY (USA): McGraw-Hill, Inc., 1991.
2. Ketterer B, Harris JM, Talaska G, et al. The human glutathione S-transferase supergene family, its polymorphism, and its effect on susceptibility to lung cancer. Environ Health Persp 1992; 98: 87-94.
3. Kadlubar FF, Hammons GJ. Role of cytochrome P-450 in metabolism of chemical carcinogens. In: Guengerich FP, ed. Mammalian Cytochromes P-450. Volume 2. Boca Raton FL (USA): CRC Press, 1987: 81-130.
4. Peterson DD, McKinney CE, Ikeya K, et al. Human CYP1A1 gene: Cosegregation of the enzyme inducibility phenotype and a RFLP. Am J Hum Genet 1991; 48: 720-5.
5. Hayashi S, Watanabe J, Nakachi K, Kawajiri K. Genetic linkage of lung cancer associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450 1A1 gene. J Biochem 1991; 110: 407-11.
6. Cosma G, Crofts F, Taioli E, Toniolo P, Garte S. Relationship between genotype and function of the human CYP1A1 gene. J Toxicol Environ Health 1993; 40: 309-19.
7. Crofts F, Taioli E, Trachman J, et al. Functional significance of different human CYP1A1 genotypes. Carcinogenesis 1994; 15: 2961-3.
8. Nakachi K, Imai K, Hayashi S, Watanabe J, Kawajiri K. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res 1991; 51: 5177-80.
9. Kawajiri N, Nakachi K, Imai K, Yoshii A, Shinoda N, Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P4501A1 gene. FEBS 1990; 263: 131-3.
10. Hayashi S, Watanabe J, Kawajiri K. High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and Mu-class glutathione S-transferase genes. Jpn J Cancer Res 1992; 83: 866-70.
11. Nakachi K, Imai K, Hayashi S, Kawajiri K. Polymorphisms of the CYP1A1 and the glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res 1993; 53: 2994-9.
12. Drakoulis N, Cascorbi I, Brokmoller J, Gross CR, Roots I. Polymorphisms in the human CYP1A1 gene as susceptibility factors for lung cancer: exon-7 mutation (4889 A to G), and a T to C mutation in the 3'-flanking region. Clin Investig 1994; 72: 240-8.
13. Hirvonen A, Husgafvel-Pursiainen K, Karjalainen A, Antila S, Vainio H. Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finish study population. Cancer Epidemiol Biomark Prev 1992; 1: 485-9.
14. Shields PG, Caporaso NE, Falk RT, et al. Lung cancer, race, and a CYP1A1 genetic polymorphism. Cancer Epidemiol Biomark Prev 1993; 2: 481-5.
15. Sugimura H, Hamada GS, Suzuki I, et al. CYP1A1 and CYP2E1 polymorphism and lung cancer, case-control study in Rio de Janeiro, Brazil. Pharmacogenetics 1995; 5: S145-8.
16. Seidegård J, Vorachek WR, Pero RW, Pearson WR. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci 1988; 85: 7593-7.
17. Zhong S, Howie AF, Ketterer B, et al. Glutathione S-tranferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis 1991; 12: 1533-7.
18. Brockmöller J, Gross D, Kerb R, Dakoulis N, Roots I. Correlation between trans-stilbene oxide-glutathione activity and the deletion mutation in the glutathione S-transferase class Mu gene detected by polymerase chain reaction. Biochem Pharmacol 1992; 43: 650-4.
19. McWilliams JE, Sanderson BJS, Harris EL, Richert-Boe KE, Henner WD. Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol Biomark Prev 1995; 5: 589-94.
20. London SJ, Daly AK, Cooper J, Navidi WC, Carpenter CL, Idle JR. Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California. JNCI 1995; 87: 1246-53.
21. To-Figueras J, Gené M, Gómez-Catalán J, et al. Gluthathione S-transferase M1 and codon 72 P53 polymorphism in a Northwestern Mediterranean population and their relation to lung cancer susceptibility. Cancer Epidemiol Biomark Prev 1996; 5: 337-43.
22. Nazar-Stewart V, Mutulsky AG, Eaton DL, et al. The glutathione S-transferase mu polymorphisms as a marker for susceptibility to lung cancer. Cancer Res 1993; 53(Suppl): 2313-8.
23. Hirvonen A, Husgafvel-Pursiainen K, Anttila S, Vainio H. The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis 1993; 14: 1479-81.
24. Kihara M, Khiara M, Noda K. Lung cancer risk of GSTM1 null genotype is dependent on the extent of tobacco smoke exposure. Carcinogenesis 1994; 15: 415-8.
25. Alexandrie AK, Sundberg MI, Seidegård J, Tornling G, Rannug A. Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis 1994; 15: 1785-90.
26. Anttila S, Hirvonen A, Husgafvel-Pursiainen K, Karjalainen A, Nurminen T, Vainio H. Combined effect of CYP1A1 inducibility and GSTM1 polymorphism on histological type of lung cancer. Carcinogenesis 1994; 15: 1133-5.
27. Xu X, Kelsey K, Wiencke J, Wain J, Christiani D. Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomark Prev 1996; 5: 687-92.
28. Ferris BG. Epidemiology standardization project. Am Rev Respir Dis 1978; 118(Part 2): 1-120.
29. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985; 122: 51-65.
30. García-Closas M, Kelsey KT, Wiencke JK, Wain JC, Christiani DC. Dietary intake as a modifier of the association between GSTM1 and CYP1A1 MspI polymorphisms and lung cancer susceptibility. Doctoral Thesis, Chapter 3. Harvard School of Public Health, Boston, MA, 1996.
31. Walsh PS, Metzger DA, Higuchi R. Chelex 100 as medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques 1991; 10: 506-13.
32. Chen H, Sandler DP, Taylor JA, et al. Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet 1996; 347: 295-6.
33. Cheng TJ, Christiani DC, Xu X, Wain JC, Wiencke JK, Kelsey KT. Glutathione S-transferase μ genotype, diet, and smoking as determinants of sister chromatid exchange frequency in lymphocytes. Cancer Epidemiol Biomarkers Prev 1995; 4: 535-42.
34. Hastie TJ, Tibshirani RJ. Generalized Additive Models. London, UK: Chapman & Hall, 1990:
35. Brockmöller J, Kerb R, Drakoulis N, Nitz M, Roots I. Genotype and phenotype of glutathione S-transferase class p isoenzymes and in lung cancer patients and controls. Cancer Res 1993; 53: 1004-11.
36. Lin HJ, Han C-Y, Bernstein DA, Hsiao W, Lin BK, Hardy S. Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility. Carcinogenesis 1994; 15: 1077-81.
37. Poppel GV, Vogel NCL Balderen PJV, Kok FJ. Increase cytogenetic damage in smokers deficient in glutathione S-transferase isoenzyme mu. Carcinogenesis 1992; 13: 303-5.
38. Kihara M, Kihara M, Noda K. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis 1995; 16: 2331-6.
39. Robins J, Pike M. The validity of case-control studies with nonrandom selection of controls. Epidemiology 1990; 1: 273-84.
40. Nakachi K, Hayashi S-i, Kawajiri K, Imai K. Association of cigarette smoking and CYP1A1 polymorphisms with adenocarcinoma of the lung by grades of differentiation. Carcinogenesis 1995; 16: 2209-13.
41. Okada T, Kawashima K, Fukushi S, Minakuchi T, Nishimura S. Association between a cytochrome P450 CYP1A1 genotype and incidence of lung cancer. Pharmacogenetics 1994; 4: 333-40.